{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:57:19Z","timestamp":1789725439337,"version":"4.0.1"},"reference-count":117,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.1093\/humupd\/dmm034","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T01:43:33Z","timestamp":1195177413000},"page":"1-14","source":"Crossref","is-referenced-by-count":171,"title":["Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation"],"prefix":"10.1093","volume":"14","author":[{"given":"B.C.J.M.","family":"Fauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Devroey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"key\n\t\t\t\t20171010222110_DMM034C1","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/humrep\/deg208","article-title":"Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS","volume":"18","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171010222110_DMM034C3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750.pub2","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany","year":"2006"},{"key":"key\n\t\t\t\t20171010222110_DMM034C4","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/bmj.281.6255.1612","article-title":"Statistics and ethics in medical research. VII \u2013 Interpreting results","volume":"281","author":"Altman","year":"1980","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171010222110_DMM034C5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1472-6483(10)60865-6","article-title":"Exploiting LH in ovarian stimulation","volume":"12","author":"Alviggi","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C6","first-page":"191","article-title":"Inhibin and related peptides in the regulation of reproduction","volume":"15","author":"Baird","year":"1993","journal-title":"Oxf Rev Reprod Biol"},{"key":"key\n\t\t\t\t20171010222110_DMM034C7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.fpc.0000167330.92786.5e","article-title":"Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation","volume":"15","author":"Behre","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"key\n\t\t\t\t20171010222110_DMM034C8","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/humrep\/dei101","article-title":"IVF\/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression","volume":"20","author":"Bjercke","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171010222110_DMM034C10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tem.2007.01.004","article-title":"Female reproductive ageing: current knowledge and future trends","volume":"18","author":"Broekmans","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fertnstert.2004.06.050","article-title":"Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone","volume":"83","author":"Cabrera","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1472-6483(10)61123-6","article-title":"Recombinant LH in ovarian stimulation","volume":"10","author":"Caglar","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/humrep\/13.2.403","article-title":"Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles","volume":"13","author":"Croucher","year":"1998","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/oxfordjournals.humrep.a019451","article-title":"Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation","volume":"11","author":"Danninger","year":"1996","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humrep\/deh625","article-title":"Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial","volume":"20","author":"De Placido","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0015-0282(99)00334-9","article-title":"Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts","volume":"72","author":"De Vries","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171010222110_DMM034C18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmi025","article-title":"Genetics of PCOS: searching for the way out of the labyrinth","volume":"11","author":"Diamant-Kandarakis","year":"2005","journal-title":"Hum Reprod Upd"},{"key":"key\n\t\t\t\t20171010222110_DMM034C19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jcem.87.3.8319","article-title":"A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure","volume":"87","author":"Doherty","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20171010222110_DMM034C21","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/humrep\/deg459","article-title":"High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2)","volume":"18","author":"Eijkemans","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09513590400021128","article-title":"Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: a prospective study","volume":"20","author":"Elter","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20171010222110_DMM034C23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(99)00090-4","article-title":"Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization","volume":"71","author":"Enskog","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0378(00)00075-9","article-title":"Low peripheral blood levels of the immunosuppressive cytokine interleukin 10 (IL-10) at the start of gonadotrophin stimulation indicates increased risk for development of ovarian hyperstimulation syndrome (OHSS)","volume":"49","author":"Enskog","year":"2001","journal-title":"J Reprod Immunol"},{"key":"key\n\t\t\t\t20171010222110_DMM034C25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the PCOS","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20171010222110_DMM034C26","first-page":"71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20171010222110_DMM034C27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.fertnstert.2004.06.041","article-title":"Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques","volume":"82","author":"Ferraretti","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C28","first-page":"P-301","article-title":"Prediction of an appropriate number of mature follicles after low dose rFSH stimulation for intrauterine insemination","volume":"21","author":"Freiesleben","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","article-title":"Optimum number of oocytes for a successful first IVF treatment cycle","volume":"13","author":"van der Gaast","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.fertnstert.2006.10.002","article-title":"Evaluation of an existing nomogram for predicting the response to clomiphene citrate","volume":"87","author":"Ghobadi","year":"2007","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5122(98)00069-3","article-title":"Ovarian follicular growth in humans: ovarian ageing and population of growing follicles","volume":"30","author":"Gougeon","year":"1998","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t20171010222110_DMM034C32","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1210\/jc.2004-2268","article-title":"A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle","volume":"90","author":"Greb","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1472-6483(10)61990-6","article-title":"Role of LH in ovarian stimulation: considerations","volume":"12","author":"Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0015-0282(03)00741-6","article-title":"Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting","volume":"80","author":"Hansen","year":"2003","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20171010222110_DMM034C36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(00)01643-5","article-title":"A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles","volume":"75","author":"Harrison","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C37","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/B:JARG.0000027016.65749.ad","article-title":"Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF)","volume":"21","author":"Hendriks","year":"2004","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.fertnstert.2004.10.011","article-title":"Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level","volume":"83","author":"Hendriks","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C40","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate\u2013end of an era? A mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF02212923","article-title":"The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?","volume":"12","author":"van Hooff","year":"1995","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.humrep.a138053","article-title":"Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study","volume":"8","author":"van Hooff","year":"1993","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1023\/A:1020358419073","article-title":"A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF\/ICSI","volume":"19","author":"Hoomans","year":"2002","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0015-0282(01)03237-X","article-title":"Ovarian response in three consecutive in vitro fertilization cycles","volume":"77","author":"Hoveyda","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C45","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1185\/030079906X104678","article-title":"Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients","volume":"22","author":"Howles","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20171010222110_DMM034C46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1472-6483(10)60998-4","article-title":"To add or not to add LH: comments on a recent commentary","volume":"12","author":"Humaidan","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1472-6483(10)61643-4","article-title":"Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study","volume":"8","author":"Humaidan","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C48","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C49","first-page":"1617","article-title":"Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"84","author":"Imani","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C50","first-page":"676","article-title":"Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"85","author":"Imani","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0015-0282(01)02928-4","article-title":"Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency","volume":"a77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"b77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0303-7207(01)00467-1","article-title":"Anti-Mullerian hormone and its receptors","volume":"179","author":"Josso","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t20171010222110_DMM034C54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10038-006-0005-5","article-title":"Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET","volume":"51","author":"Jun","year":"2006","journal-title":"J Hum Genet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C55","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/humrep\/dem036","article-title":"Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women","volume":"22","author":"Kevenaar","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0301-2115(02)00036-2","article-title":"Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response","volume":"103","author":"Khalaf","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171010222110_DMM034C57","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.fertnstert.2003.10.030","article-title":"A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles","volume":"81","author":"Klinkert","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1472-6483(10)60660-8","article-title":"FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF","volume":"13","author":"Klinkert","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C59","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)61680-X","article-title":"To add or not to add LH: consideration of LH concentration changes in individual patients","volume":"11","author":"Kol","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0015-0282(02)02975-8","article-title":"Effect of repeated assisted reproductive technology cycles on ovarian response","volume":"77","author":"Kolibianakis","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humupd\/dmi030","article-title":"Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171010222110_DMM034C62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/humrep\/dei317","article-title":"The distribution of FSH receptorisoforms is related to basal FSH levels in subfertile women with normal menstrual cycles","volume":"21","author":"de Koning","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C63","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/humrep\/deh119","article-title":"Intercycle variability of ovarian reserve tests: results of a prospective randomized study","volume":"19","author":"Kwee","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C64","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.fertnstert.2005.11.053","article-title":"The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization","volume":"85","author":"Kwee","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C65","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/humrep\/del421","article-title":"Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","volume":"22","author":"La Marca","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C67","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/humrep\/del219","article-title":"A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF\/ICSI cycles leads to lower live birth rates","volume":"21","author":"Lahoud","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C68","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0015-0282(16)58269-7","article-title":"High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome","volume":"65","author":"Land","year":"1996","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF02744938","article-title":"Superovulation with a high gonadotropin dose for in vitro fertilization: is it effective? J Assist","volume":"15","author":"Lashen","year":"1998","journal-title":"Reprod Genet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0015-0282(02)03202-8","article-title":"Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins","volume":"78","author":"Lass","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C71","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0015-0282(01)02844-8","article-title":"A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization","volume":"76","author":"Latin-American Puregon IVF Study Group","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C72","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0015-0282(03)01115-4","article-title":"FSH receptor polymorphisms in women with normogonadotropic anovulatory infertility","volume":"80","author":"Laven","year":"2003","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C73","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2006-0548","article-title":"Editorial: BMP15\u2013the first true ovarian determinant gene on the X-chromosome?","volume":"91","author":"Layman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171010222110_DMM034C75","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/humrep\/14.10.2437","article-title":"Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration","volume":"14","author":"Ludwig","year":"1999","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1472-6483(10)60513-5","article-title":"Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment","volume":"8","author":"Marrs","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C77","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C78","first-page":"200","article-title":"Initial and cyclic recruitment of ovarian follicles","volume":"21","author":"McGee","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20171010222110_DMM034C79","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1210\/jc.2003-030217","article-title":"Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies","volume":"88","author":"Meduri","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C80","first-page":"114","article-title":"Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle","volume":"41","author":"Miao","year":"2006","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"key\n\t\t\t\t20171010222110_DMM034C81","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1472-6483(10)61747-6","article-title":"Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility","volume":"a7","author":"Mulders","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171010222110_DMM034C82","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/humupd\/dmg035","article-title":"Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis","volume":"b9","author":"Mulders","year":"2003","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171010222110_DMM034C83","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2005.10.052","article-title":"Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization","volume":"85","author":"Nakhuda","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10815-005-6785-2","article-title":"The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination","volume":"22","author":"Ng","year":"2005","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C85","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/bmj.302.6789.1361","article-title":"Delaying childbearing: effect of age on fecundity and outcome of pregnancy","volume":"302","author":"van Noord-Zaadstra","year":"1991","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171010222110_DMM034C86","doi-asserted-by":"crossref","DOI":"10.5935\/1518-0557.2006.10.4.08","article-title":"Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysis","author":"Oliveira","year":"2006","journal-title":"J Assist Reprod Genet."},{"key":"key\n\t\t\t\t20171010222110_DMM034C87","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/humrep\/14.3.622","article-title":"A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation","volume":"14","author":"Out","year":"1999","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C88","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/humrep\/16.6.1104","article-title":"A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles","volume":"16","author":"Out","year":"2001","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deh044","article-title":"A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction","volume":"19","author":"Out","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C90","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/oxfordjournals.humrep.a135890","article-title":"Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome","volume":"10","author":"Oyesanya","year":"1995","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C91","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C92","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/humrep\/deg506","article-title":"LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH","volume":"18","author":"Penarrubia","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C93","first-page":"3365","article-title":"Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype","volume":"85","author":"Perez Mayorga","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C94","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a \u2018standard\u2019 dose of 150 IU\/day in \u2018standard\u2019 patients undergoing IVF\/ICSI treatment","volume":"a18","author":"Popovic-Todorovic","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C95","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/humrep\/deg181","article-title":"A prospective study of predictive factors of ovarian response in \u2018standard\u2019 IVF\/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram","volume":"b18","author":"Popovic-Todorovic","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C96","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.0001-6349.2004.00573.x","article-title":"Impact of recombinant FSH dose adjustments on ovarian response in the second treatment cycle with IVF or ICSI in \u2018standard\u2019 patients treated with 150 IU\/day during the first cycle","volume":"83","author":"Popovic-Todorovic","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20171010222110_DMM034C97","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/humrep\/dei074","article-title":"Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome","volume":"20","author":"Ragni","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C98","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/oxfordjournals.humrep.a137642","article-title":"Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures","volume":"7","author":"Rizk","year":"1992","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C99","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/humrep\/deg515","article-title":"Is there a future for ovulation induction in the current era of assisted reproduction?","volume":"18","author":"van Santbrink","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tem.2005.08.006","article-title":"Patient-tailored conventional ovulation induction algorithms in anovulatory infertility","volume":"16","author":"van Santbrink","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t20171010222110_DMM034C101","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0015-0282(99)00396-9","article-title":"Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility","volume":"72","author":"Scheffer","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C102","first-page":"270","article-title":"Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet","volume":"20","author":"Scheffer","year":"2002","journal-title":"Gynecol"},{"key":"key\n\t\t\t\t20171010222110_DMM034C103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0015-0282(16)53707-8","article-title":"Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization","volume":"54","author":"Scott","year":"1990","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C104","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0015-0282(02)03160-6","article-title":"Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility","volume":"78","author":"Sharma","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C106","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.290.13.1767","article-title":"Diagnosis and management of female infertility","volume":"290","author":"Smith","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171010222110_DMM034C107","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/molehr\/8.10.893","article-title":"Genetic and functional analyses of polymorphisms in the human FSH receptor gene","volume":"8","author":"Sudo","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C108","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(96)05291-9","article-title":"Factors that affect outcome of in-vitro fertilisation treatment","volume":"348","author":"Templeton","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171010222110_DMM034C109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"The ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(99)00397-0","article-title":"Prognostic factors in controlled ovarian hyperstimulation","volume":"72","author":"Tinkanen","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C111","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20171010222110_DMM034C112","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"AMH expression pattern in the human ovary; potential implications for intitial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C113","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/humrep\/deh891","article-title":"Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome","volume":"20","author":"van Wely","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C114","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.fertnstert.2006.05.046","article-title":"Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome","volume":"86","author":"van Wely","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171010222110_DMM034C115","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/humrep\/14.3.689","article-title":"How concordant are the estimated rates of natural conception and in-vitro fertilization\/embryo transfer success?","volume":"14","author":"Wiegerinck","year":"1999","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C116","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/humrep\/16.8.1676","article-title":"A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF\/ICSI","volume":"16","author":"Wikland","year":"2001","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171010222110_DMM034C117","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0015-0282(02)04583-1","article-title":"A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment","volume":"79","author":"Yong","year":"2003","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/14\/1\/1\/2458995\/dmm034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:59:56Z","timestamp":1708315196000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humupd\/article\/14\/1\/1\/823980\/Predictors-of-ovarian-response-progress-towards"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,11,15]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmm034","relation":{},"ISSN":["1460-2369","1355-4786"],"issn-type":[{"value":"1460-2369","type":"electronic"},{"value":"1355-4786","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,1]]},"published":{"date-parts":[[2007,11,15]]}}}